ADHD Therapeutics Market to 2027 - Global Analysis and Forecasts By Drug Type ( Stimulants, Non-Stimulants ); Age Group ( Pediatric, Adolescent, Adults ); Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, e-Commerce ) and Geography
Report Code: TIPRE00003833 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Attention Deficit/Hyperactivity Disorder (ADHD) is one of the psychiatric disorder that mainly occurs in children and adolescents. The diagnosis of ADHD is difficult due to unknown genetic causes and a lack of accurate biomarkers. Psychostimulants are the primarily recommended therapeutics for the treatment of ADHD as its helps to reduce or prevent symptoms of hyperactivity, inattention, and impulsivity in order to improve quality of life.
MARKET DYNAMICS
The ADHD therapeutics market is anticipated to grow in the forecast, owing to the factors such as increasing lifestyle diseases, increasing use of additives and preservations in children's diet, and others. In addition, development of new and effective therapeutics is likely to offer growth opportunities in the market.
MARKET SCOPE
The "Global ADHD Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of ADHD therapeutics market with detailed market segmentation drug class, age group, distribution channel and geography. The global ADHD therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading ADHD therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global ADHD therapeutics market is segmented on the basis of drug class, age group, distribution channel and geography. Based on drug class, the market is segmented into stimulants and non-stimulants. Based on age group, the global ADHD therapeutics market is segmented into pediatric, adolescent and adults. On the basis of distribution channel, the ADHD therapeutics market is segmented into hospital pharmacies, retail pharmacies and e-Commerce.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global ADHD therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The ADHD therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting ADHD therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the ADHD therapeutics market in these regions.
MARKET PLAYERS
The reports cover key developments in the ADHD therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from ADHD therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for ADHD therapeutics market in the global market. Below mentioned is the list of few companies engaged in the ADHD therapeutics market.
The report also includes the profiles of key ADHD therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Attention Deficit/Hyperactivity Disorder (ADHD) is one of the psychiatric disorder that mainly occurs in children and adolescents. The diagnosis of ADHD is difficult due to unknown genetic causes and a lack of accurate biomarkers. Psychostimulants are the primarily recommended therapeutics for the treatment of ADHD as its helps to reduce or prevent symptoms of hyperactivity, inattention, and impulsivity in order to improve quality of life.
MARKET DYNAMICS
The ADHD therapeutics market is anticipated to grow in the forecast, owing to the factors such as increasing lifestyle diseases, increasing use of additives and preservations in children's diet, and others. In addition, development of new and effective therapeutics is likely to offer growth opportunities in the market.
MARKET SCOPE
The "Global ADHD Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of ADHD therapeutics market with detailed market segmentation drug class, age group, distribution channel and geography. The global ADHD therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading ADHD therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global ADHD therapeutics market is segmented on the basis of drug class, age group, distribution channel and geography. Based on drug class, the market is segmented into stimulants and non-stimulants. Based on age group, the global ADHD therapeutics market is segmented into pediatric, adolescent and adults. On the basis of distribution channel, the ADHD therapeutics market is segmented into hospital pharmacies, retail pharmacies and e-Commerce.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global ADHD therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The ADHD therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting ADHD therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the ADHD therapeutics market in these regions.
The reports cover key developments in the ADHD therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from ADHD therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for ADHD therapeutics market in the global market. Below mentioned is the list of few companies engaged in the ADHD therapeutics market.
The report also includes the profiles of key ADHD therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Eli Lilly and Company
- Novartis AG
- Pfizer, Inc.
- GlaxoSmithKline plc
- Mallinckrodt Pharmaceuticals
- Hisamitsu Pharmaceutical Co.,Inc.
- Johnson & Johnson Services, Inc.
- UCB S.A.
- Purdue Pharma L.P.
- Impax Laboratories, LLC
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 ADHD Therapeutics Market - By Drug Type
1.3.2 ADHD Therapeutics Market - By Age Group
1.3.3 ADHD Therapeutics Market - By Distribution Channel
1.3.4 ADHD Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ADHD THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ADHD THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ADHD THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ADHD THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ADHD THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ADHD THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. STIMULANTS
7.3.1. Overview
7.3.2. Stimulants Market Forecast and Analysis
7.3.3. Amphetamine Market
7.3.3.1. Overview
7.3.3.2. Amphetamine Market Forecast and Analysis
7.3.4. Methylphenidate Market
7.3.4.1. Overview
7.3.4.2. Methylphenidate Market Forecast and Analysis
7.3.5. Dextroamphetamine Market
7.3.5.1. Overview
7.3.5.2. Dextroamphetamine Market Forecast and Analysis
7.3.6. Dexmethylphenidate Market
7.3.6.1. Overview
7.3.6.2. Dexmethylphenidate Market Forecast and Analysis
7.3.7. Lisdexamfetamine Dimesylate Market
7.3.7.1. Overview
7.3.7.2. Lisdexamfetamine Dimesylate Market Forecast and Analysis
7.4. NON-STIMULANTS
7.4.1. Overview
7.4.2. Non-Stimulants Market Forecast and Analysis
7.4.3. Atomoxetine Market
7.4.3.1. Overview
7.4.3.2. Atomoxetine Market Forecast and Analysis
7.4.4. Bupropion Market
7.4.4.1. Overview
7.4.4.2. Bupropion Market Forecast and Analysis
7.4.5. Guanfacine Market
7.4.5.1. Overview
7.4.5.2. Guanfacine Market Forecast and Analysis
7.4.6. Clonidine Market
7.4.6.1. Overview
7.4.6.2. Clonidine Market Forecast and Analysis
8. ADHD THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - AGE GROUP
8.1. OVERVIEW
8.2. AGE GROUP MARKET FORECASTS AND ANALYSIS
8.3. PEDIATRIC
8.3.1. Overview
8.3.2. Pediatric Market Forecast and Analysis
8.4. ADOLESCENT
8.4.1. Overview
8.4.2. Adolescent Market Forecast and Analysis
8.5. ADULTS
8.5.1. Overview
8.5.2. Adults Market Forecast and Analysis
9. ADHD THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. E-COMMERCE
9.5.1. Overview
9.5.2. e-Commerce Market Forecast and Analysis
10. ADHD THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America ADHD Therapeutics Market Overview
10.1.2 North America ADHD Therapeutics Market Forecasts and Analysis
10.1.3 North America ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.1.4 North America ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.1.5 North America ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States ADHD Therapeutics Market
10.1.6.1.1 United States ADHD Therapeutics Market by Drug Type
10.1.6.1.2 United States ADHD Therapeutics Market by Age Group
10.1.6.1.3 United States ADHD Therapeutics Market by Distribution Channel
10.1.6.2 Canada ADHD Therapeutics Market
10.1.6.2.1 Canada ADHD Therapeutics Market by Drug Type
10.1.6.2.2 Canada ADHD Therapeutics Market by Age Group
10.1.6.2.3 Canada ADHD Therapeutics Market by Distribution Channel
10.1.6.3 Mexico ADHD Therapeutics Market
10.1.6.3.1 Mexico ADHD Therapeutics Market by Drug Type
10.1.6.3.2 Mexico ADHD Therapeutics Market by Age Group
10.1.6.3.3 Mexico ADHD Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe ADHD Therapeutics Market Overview
10.2.2 Europe ADHD Therapeutics Market Forecasts and Analysis
10.2.3 Europe ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.2.4 Europe ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.2.5 Europe ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany ADHD Therapeutics Market
10.2.6.1.1 Germany ADHD Therapeutics Market by Drug Type
10.2.6.1.2 Germany ADHD Therapeutics Market by Age Group
10.2.6.1.3 Germany ADHD Therapeutics Market by Distribution Channel
10.2.6.2 France ADHD Therapeutics Market
10.2.6.2.1 France ADHD Therapeutics Market by Drug Type
10.2.6.2.2 France ADHD Therapeutics Market by Age Group
10.2.6.2.3 France ADHD Therapeutics Market by Distribution Channel
10.2.6.3 Italy ADHD Therapeutics Market
10.2.6.3.1 Italy ADHD Therapeutics Market by Drug Type
10.2.6.3.2 Italy ADHD Therapeutics Market by Age Group
10.2.6.3.3 Italy ADHD Therapeutics Market by Distribution Channel
10.2.6.4 Spain ADHD Therapeutics Market
10.2.6.4.1 Spain ADHD Therapeutics Market by Drug Type
10.2.6.4.2 Spain ADHD Therapeutics Market by Age Group
10.2.6.4.3 Spain ADHD Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom ADHD Therapeutics Market
10.2.6.5.1 United Kingdom ADHD Therapeutics Market by Drug Type
10.2.6.5.2 United Kingdom ADHD Therapeutics Market by Age Group
10.2.6.5.3 United Kingdom ADHD Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific ADHD Therapeutics Market Overview
10.3.2 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.3.5 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia ADHD Therapeutics Market
10.3.6.1.1 Australia ADHD Therapeutics Market by Drug Type
10.3.6.1.2 Australia ADHD Therapeutics Market by Age Group
10.3.6.1.3 Australia ADHD Therapeutics Market by Distribution Channel
10.3.6.2 China ADHD Therapeutics Market
10.3.6.2.1 China ADHD Therapeutics Market by Drug Type
10.3.6.2.2 China ADHD Therapeutics Market by Age Group
10.3.6.2.3 China ADHD Therapeutics Market by Distribution Channel
10.3.6.3 India ADHD Therapeutics Market
10.3.6.3.1 India ADHD Therapeutics Market by Drug Type
10.3.6.3.2 India ADHD Therapeutics Market by Age Group
10.3.6.3.3 India ADHD Therapeutics Market by Distribution Channel
10.3.6.4 Japan ADHD Therapeutics Market
10.3.6.4.1 Japan ADHD Therapeutics Market by Drug Type
10.3.6.4.2 Japan ADHD Therapeutics Market by Age Group
10.3.6.4.3 Japan ADHD Therapeutics Market by Distribution Channel
10.3.6.5 South Korea ADHD Therapeutics Market
10.3.6.5.1 South Korea ADHD Therapeutics Market by Drug Type
10.3.6.5.2 South Korea ADHD Therapeutics Market by Age Group
10.3.6.5.3 South Korea ADHD Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa ADHD Therapeutics Market Overview
10.4.2 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.4.5 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa ADHD Therapeutics Market
10.4.6.1.1 South Africa ADHD Therapeutics Market by Drug Type
10.4.6.1.2 South Africa ADHD Therapeutics Market by Age Group
10.4.6.1.3 South Africa ADHD Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia ADHD Therapeutics Market
10.4.6.2.1 Saudi Arabia ADHD Therapeutics Market by Drug Type
10.4.6.2.2 Saudi Arabia ADHD Therapeutics Market by Age Group
10.4.6.2.3 Saudi Arabia ADHD Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E ADHD Therapeutics Market
10.4.6.3.1 U.A.E ADHD Therapeutics Market by Drug Type
10.4.6.3.2 U.A.E ADHD Therapeutics Market by Age Group
10.4.6.3.3 U.A.E ADHD Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America ADHD Therapeutics Market Overview
10.5.2 South and Central America ADHD Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.5.5 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil ADHD Therapeutics Market
10.5.6.1.1 Brazil ADHD Therapeutics Market by Drug Type
10.5.6.1.2 Brazil ADHD Therapeutics Market by Age Group
10.5.6.1.3 Brazil ADHD Therapeutics Market by Distribution Channel
10.5.6.2 Argentina ADHD Therapeutics Market
10.5.6.2.1 Argentina ADHD Therapeutics Market by Drug Type
10.5.6.2.2 Argentina ADHD Therapeutics Market by Age Group
10.5.6.2.3 Argentina ADHD Therapeutics Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ADHD THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY AND COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MALLINCKRODT PHARMACEUTICALS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HISAMITSU PHARMACEUTICAL CO.,INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JOHNSON AND JOHNSON SERVICES, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. UCB S.A.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PURDUE PHARMA L.P.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. IMPAX LABORATORIES, LLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 ADHD Therapeutics Market - By Drug Type
1.3.2 ADHD Therapeutics Market - By Age Group
1.3.3 ADHD Therapeutics Market - By Distribution Channel
1.3.4 ADHD Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ADHD THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ADHD THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ADHD THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ADHD THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ADHD THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ADHD THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. STIMULANTS
7.3.1. Overview
7.3.2. Stimulants Market Forecast and Analysis
7.3.3. Amphetamine Market
7.3.3.1. Overview
7.3.3.2. Amphetamine Market Forecast and Analysis
7.3.4. Methylphenidate Market
7.3.4.1. Overview
7.3.4.2. Methylphenidate Market Forecast and Analysis
7.3.5. Dextroamphetamine Market
7.3.5.1. Overview
7.3.5.2. Dextroamphetamine Market Forecast and Analysis
7.3.6. Dexmethylphenidate Market
7.3.6.1. Overview
7.3.6.2. Dexmethylphenidate Market Forecast and Analysis
7.3.7. Lisdexamfetamine Dimesylate Market
7.3.7.1. Overview
7.3.7.2. Lisdexamfetamine Dimesylate Market Forecast and Analysis
7.4. NON-STIMULANTS
7.4.1. Overview
7.4.2. Non-Stimulants Market Forecast and Analysis
7.4.3. Atomoxetine Market
7.4.3.1. Overview
7.4.3.2. Atomoxetine Market Forecast and Analysis
7.4.4. Bupropion Market
7.4.4.1. Overview
7.4.4.2. Bupropion Market Forecast and Analysis
7.4.5. Guanfacine Market
7.4.5.1. Overview
7.4.5.2. Guanfacine Market Forecast and Analysis
7.4.6. Clonidine Market
7.4.6.1. Overview
7.4.6.2. Clonidine Market Forecast and Analysis
8. ADHD THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - AGE GROUP
8.1. OVERVIEW
8.2. AGE GROUP MARKET FORECASTS AND ANALYSIS
8.3. PEDIATRIC
8.3.1. Overview
8.3.2. Pediatric Market Forecast and Analysis
8.4. ADOLESCENT
8.4.1. Overview
8.4.2. Adolescent Market Forecast and Analysis
8.5. ADULTS
8.5.1. Overview
8.5.2. Adults Market Forecast and Analysis
9. ADHD THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. E-COMMERCE
9.5.1. Overview
9.5.2. e-Commerce Market Forecast and Analysis
10. ADHD THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America ADHD Therapeutics Market Overview
10.1.2 North America ADHD Therapeutics Market Forecasts and Analysis
10.1.3 North America ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.1.4 North America ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.1.5 North America ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States ADHD Therapeutics Market
10.1.6.1.1 United States ADHD Therapeutics Market by Drug Type
10.1.6.1.2 United States ADHD Therapeutics Market by Age Group
10.1.6.1.3 United States ADHD Therapeutics Market by Distribution Channel
10.1.6.2 Canada ADHD Therapeutics Market
10.1.6.2.1 Canada ADHD Therapeutics Market by Drug Type
10.1.6.2.2 Canada ADHD Therapeutics Market by Age Group
10.1.6.2.3 Canada ADHD Therapeutics Market by Distribution Channel
10.1.6.3 Mexico ADHD Therapeutics Market
10.1.6.3.1 Mexico ADHD Therapeutics Market by Drug Type
10.1.6.3.2 Mexico ADHD Therapeutics Market by Age Group
10.1.6.3.3 Mexico ADHD Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe ADHD Therapeutics Market Overview
10.2.2 Europe ADHD Therapeutics Market Forecasts and Analysis
10.2.3 Europe ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.2.4 Europe ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.2.5 Europe ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany ADHD Therapeutics Market
10.2.6.1.1 Germany ADHD Therapeutics Market by Drug Type
10.2.6.1.2 Germany ADHD Therapeutics Market by Age Group
10.2.6.1.3 Germany ADHD Therapeutics Market by Distribution Channel
10.2.6.2 France ADHD Therapeutics Market
10.2.6.2.1 France ADHD Therapeutics Market by Drug Type
10.2.6.2.2 France ADHD Therapeutics Market by Age Group
10.2.6.2.3 France ADHD Therapeutics Market by Distribution Channel
10.2.6.3 Italy ADHD Therapeutics Market
10.2.6.3.1 Italy ADHD Therapeutics Market by Drug Type
10.2.6.3.2 Italy ADHD Therapeutics Market by Age Group
10.2.6.3.3 Italy ADHD Therapeutics Market by Distribution Channel
10.2.6.4 Spain ADHD Therapeutics Market
10.2.6.4.1 Spain ADHD Therapeutics Market by Drug Type
10.2.6.4.2 Spain ADHD Therapeutics Market by Age Group
10.2.6.4.3 Spain ADHD Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom ADHD Therapeutics Market
10.2.6.5.1 United Kingdom ADHD Therapeutics Market by Drug Type
10.2.6.5.2 United Kingdom ADHD Therapeutics Market by Age Group
10.2.6.5.3 United Kingdom ADHD Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific ADHD Therapeutics Market Overview
10.3.2 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.3.5 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia ADHD Therapeutics Market
10.3.6.1.1 Australia ADHD Therapeutics Market by Drug Type
10.3.6.1.2 Australia ADHD Therapeutics Market by Age Group
10.3.6.1.3 Australia ADHD Therapeutics Market by Distribution Channel
10.3.6.2 China ADHD Therapeutics Market
10.3.6.2.1 China ADHD Therapeutics Market by Drug Type
10.3.6.2.2 China ADHD Therapeutics Market by Age Group
10.3.6.2.3 China ADHD Therapeutics Market by Distribution Channel
10.3.6.3 India ADHD Therapeutics Market
10.3.6.3.1 India ADHD Therapeutics Market by Drug Type
10.3.6.3.2 India ADHD Therapeutics Market by Age Group
10.3.6.3.3 India ADHD Therapeutics Market by Distribution Channel
10.3.6.4 Japan ADHD Therapeutics Market
10.3.6.4.1 Japan ADHD Therapeutics Market by Drug Type
10.3.6.4.2 Japan ADHD Therapeutics Market by Age Group
10.3.6.4.3 Japan ADHD Therapeutics Market by Distribution Channel
10.3.6.5 South Korea ADHD Therapeutics Market
10.3.6.5.1 South Korea ADHD Therapeutics Market by Drug Type
10.3.6.5.2 South Korea ADHD Therapeutics Market by Age Group
10.3.6.5.3 South Korea ADHD Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa ADHD Therapeutics Market Overview
10.4.2 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.4.5 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa ADHD Therapeutics Market
10.4.6.1.1 South Africa ADHD Therapeutics Market by Drug Type
10.4.6.1.2 South Africa ADHD Therapeutics Market by Age Group
10.4.6.1.3 South Africa ADHD Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia ADHD Therapeutics Market
10.4.6.2.1 Saudi Arabia ADHD Therapeutics Market by Drug Type
10.4.6.2.2 Saudi Arabia ADHD Therapeutics Market by Age Group
10.4.6.2.3 Saudi Arabia ADHD Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E ADHD Therapeutics Market
10.4.6.3.1 U.A.E ADHD Therapeutics Market by Drug Type
10.4.6.3.2 U.A.E ADHD Therapeutics Market by Age Group
10.4.6.3.3 U.A.E ADHD Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America ADHD Therapeutics Market Overview
10.5.2 South and Central America ADHD Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.5.5 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil ADHD Therapeutics Market
10.5.6.1.1 Brazil ADHD Therapeutics Market by Drug Type
10.5.6.1.2 Brazil ADHD Therapeutics Market by Age Group
10.5.6.1.3 Brazil ADHD Therapeutics Market by Distribution Channel
10.5.6.2 Argentina ADHD Therapeutics Market
10.5.6.2.1 Argentina ADHD Therapeutics Market by Drug Type
10.5.6.2.2 Argentina ADHD Therapeutics Market by Age Group
10.5.6.2.3 Argentina ADHD Therapeutics Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ADHD THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY AND COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MALLINCKRODT PHARMACEUTICALS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HISAMITSU PHARMACEUTICAL CO.,INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JOHNSON AND JOHNSON SERVICES, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. UCB S.A.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PURDUE PHARMA L.P.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. IMPAX LABORATORIES, LLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Eli Lilly and Company
2. Novartis AG
3. Pfizer, Inc.
4. GlaxoSmithKline plc
5. Mallinckrodt Pharmaceuticals
6. Hisamitsu Pharmaceutical Co. ,Inc.
7. Johnson & Johnson Services, Inc.
8. UCB S. A.
9. Purdue Pharma L. P.
10. Impax Laboratories, LLC
1. Eli Lilly and Company
2. Novartis AG
3. Pfizer, Inc.
4. GlaxoSmithKline plc
5. Mallinckrodt Pharmaceuticals
6. Hisamitsu Pharmaceutical Co. ,Inc.
7. Johnson & Johnson Services, Inc.
8. UCB S. A.
9. Purdue Pharma L. P.
10. Impax Laboratories, LLC